Sho Fujisawa
6PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 04, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation.Feven Tameire, Paulina Wojnarowicz, Crissy Dudgeon
|Aug 20, 2025
In Vivo Tumor Growth Control by General Control Nonderepressible 2-Targeting Agents Results from Kinase Activation.Feven Tameire, Paulina Wojnarowicz, Crissy Dudgeon
|Mar 07, 2025
Projections from ventral hippocampus to nucleus accumbens' cholinergic neurons are altered in depression.Lucian Medrihan, Margarete G Knudsen, Tatiana Ferraro
|Nov 20, 2023
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.Veronica Calvo, Wei Zheng, Anna Adam-Artigues
|Sep 21, 2023
PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.Michael E Stokes, Veronica Calvo, Sho Fujisawa
|Jan 04, 2020
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary.Sarah H Kim, Arnaud Da Cruz Paula, Thais Basili
Pageof 1
Frequent Collaborators
4 joint publications
David Surguladze
4 joint publications
Mark Mulvihill
3 joint publications
Alan C Rigby
3 joint publications
Nandita Bose
3 joint publications
Eric S Lightcap
3 joint publications
Simon J Taylor
3 joint publications
Crissy Dudgeon
2 joint publications
Earl May
2 joint publications
Kirk A Staschke
2 joint publications
Michael E Stokes
